CD
Chai DiscoveryChai Discovery builds generative AI foundation models that predict and design protein and antibody structures to accelerate pre-clinical drug discovery.
2 Pulse stories
TB
Triveni BioTriveni Bio develops genetics-informed antibody and bispecific therapeutics for immunological and inflammatory diseases.
2 Pulse stories
Total Raised
$600M
$272M
Chai DiscoveryTriveni Bio
Last Valuation
$3.8B
Chai DiscoveryTriveni Bio
Biotech
Sector
Biotech
2024
Founded
2023
San Francisco, CA
HQ
Waltham, Massachusetts
Private
Status
Private
Chai Discovery investors
Index VenturesSequoia CapitalDimensionKleiner Perkins
Triveni Bio investors
Atlas VentureCormorant Asset ManagementAscenta CapitalJanus Henderson InvestorsDeep Track CapitalOrbiMedViking Global InvestorsFidelity Management & Research
Data from Value Add Pulse coverage and company research — see the full threads for Chai Discovery and Triveni Bio.